Case Study

BIT Group Partnership With Qorvo Biotechnologies to Commercialize Innovative POC Testing Solution Utilizing BIT’s Lifecycle Management Processes

Tuesday, August 6, 12 – 12:20 p.m.
Exhibit Hall, Theater 3
Supported by BIT Group

Overview

BIT Group recently partnered with Qorvo Biotechnologies to help evolve their proprietary Bulk Acoustic Wave (BAW) POC technology from prototype to full commercial product. By partnering with BIT Group, Qorvo Biotechnologies is able to leverage the product development expertise, full manufacturing capabilities (ISO 13485), in-house technical service, and life cycle management processes developed through 40 years of experience in this space. Qorvo Biotechnologies can now rapidly and efficiently enter the market with an innovative platform and detection core, breaking technological barriers that have limited the ubiquitous deployment of liquid-based biosensors across all markets, and enabling clinicians to ultimately improve patient outcomes.

Outcomes

After attending this session, participants will be able to:

  • Understand Qorvo Biotechnologies innovative Bulk Acoustic Wave POC technology.
  • Recognize the full value BIT Group delivers to clients in evolving technology into commercial devices.
  • Appreciate the value of combining great science and experienced outsource design and manufacturing capabilities to rapidly and efficiently deliver products to the market.

Speakers

Eric Stewart
VP Global Marketing
BIT Group
Irvine, CA, USA

Bryan Bothwell
Director - Strategy and Business
Development
Qorvo Biotechnologies
Hillsboro, OR, USA